Gelesis Holdings, Inc. (GLSHQ)
USD 0.0
(-79.0%)
USD 0.0
(-79.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -57.12 Million USD | 39.05% |
| 2021 | -93.72 Million USD | -512.77% |
| 2020 | -15.29 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -7.68 Million USD | -46.42% |
| 2023 Q1 | -5.24 Million USD | 78.6% |
| 2022 FY | -57.12 Million USD | 39.05% |
| 2022 Q4 | -24.51 Million USD | -72.25% |
| 2022 Q3 | -14.22 Million USD | -12.95% |
| 2022 Q2 | -12.59 Million USD | -117.54% |
| 2022 Q1 | -5.79 Million USD | 70.12% |
| 2021 Q1 | -18.68 Million USD | -22.59% |
| 2021 Q3 | -30.82 Million USD | -24.12% |
| 2021 Q2 | -24.83 Million USD | -32.95% |
| 2021 FY | -93.72 Million USD | -512.77% |
| 2021 Q4 | -19.38 Million USD | 37.12% |
| 2020 Q4 | -15.23 Million USD | 0.0% |
| 2020 FY | -15.29 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -4177.87% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -718.12% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 207.831% |
| Nascent Biotech, Inc. | -2.08 Million USD | -2636.432% |
| Rebus Holdings, Inc. | -1.02 Million USD | -5500.784% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 187.71% |
| Qrons Inc. | -789.34 Thousand USD | -7137.375% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -8933.423% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 8.74% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -13649.913% |
| Skye Bioscience, Inc. | -37.64 Million USD | -51.755% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 23.792% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -768.72% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -20795.239% |
| SQZ Biotechnologies Company | -79.46 Million USD | 28.108% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -1875.111% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -3037.991% |
| Mesoblast Limited | -87.95 Million USD | 35.049% |
| Marizyme, Inc. | -65.34 Million USD | 12.577% |
| Genus plc | 7.9 Million USD | 823.139% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -424.508% |
| Pharming Group N.V. | -10.54 Million USD | -441.6% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -2532.852% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -1439.741% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -545.952% |
| ContraFect Corporation | -65.15 Million USD | 12.317% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -1069.203% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -3207.062% |
| IMV Inc. | -36.48 Million USD | -56.576% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -608.812% |
| MultiCell Technologies, Inc. | -380.07 USD | -15030815.358% |
| ONE Bio Corp. | 8.67 Million USD | 758.414% |
| Accustem Sciences Inc. | -3.74 Million USD | -1424.869% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -10.516% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -4408.442% |
| Q BioMed Inc. | -2.05 Million USD | -2683.889% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -1430.351% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -2299.459% |
| Biomind Labs Inc. | -1.21 Million USD | -4604.53% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 4.349% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -1741.788% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -622.856% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -2830.77% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -381363.675% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -259.942% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -882.044% |
| GB Sciences, Inc. | -1.36 Million USD | -4095.415% |
| Alpha Cognition Inc. | -13.77 Million USD | -314.796% |
| HST Global, Inc. | -146.21 Thousand USD | -38972.567% |
| CSL Limited | 2.64 Billion USD | 102.162% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -3155.581% |
| Halberd Corporation | -79.67 Thousand USD | -71600.387% |
| Enzolytics Inc. | -2.17 Million USD | -2524.364% |
| Agentix Corp. | -1.37 Million USD | -4057.149% |
| Resverlogix Corp. | -3.61 Million USD | -1482.493% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -1701.329% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 80.638% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 58393.878% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 925.001% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -1337.908% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -1787.821% |
| AVAX Technologies, Inc. | -6.41 Million USD | -790.726% |
| Zenith Capital Corp. | -10.59 Million USD | -439.147% |
| Genscript Biotech Corporation | -95.47 Million USD | 40.166% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -245696.403% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -1277.928% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -94419.231% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -2749.113% |
| Kadimastem Ltd | -3.3 Million USD | -1627.279% |
| Helix BioMedix, Inc. | -1.05 Million USD | -5309.556% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -1395.889% |
| BioStem Technologies, Inc. | -8.48 Million USD | -573.442% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -12843.365% |
| LadRx Corporation | 400.44 Thousand USD | 14366.2% |
| Cell Source, Inc. | -5.32 Million USD | -973.59% |
| Regen BioPharma, Inc. | 1.02 Million USD | 5681.588% |
| Regen BioPharma, Inc. | 1.02 Million USD | 5681.588% |
| NovAccess Global Inc. | -4.76 Million USD | -1097.856% |
| Affymax, Inc. | -14.42 Million USD | -296.062% |
| Itoco Inc. | -1.86 Million USD | -2956.616% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -1185.932% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -3322.888% |
| Mobile Lads Corp. | -2.26 Million USD | -2424.111% |
| CytoDyn Inc. | -49.84 Million USD | -14.62% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -72183.73% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -24942.191% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -5967.577% |
| SYBLEU INC | -180.3 Thousand USD | -31584.267% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -3442.301% |
| International Stem Cell Corporation | -131 Thousand USD | -43509.16% |
| Bioxytran, Inc. | -4.28 Million USD | -1234.766% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -105162.382% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -2157.803% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -18.838% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -2602.365% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -7215.783% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -1703.283% |
| Neutra Corp. | -233.46 Thousand USD | -24369.621% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -181.544% |
| PureTech Health plc | -65.69 Million USD | 13.043% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -168.629% |
| IXICO plc | -1.17 Million USD | -4749.576% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -475.481% |
| CSL Limited | 2.64 Billion USD | 102.162% |
| Cellectis S.A. | -103.17 Million USD | 44.629% |